The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBYOT.L Regulatory News (BYOT)

  • There is currently no data for BYOT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Latest developments

27 Feb 2008 07:02

Byotrol PLC27 February 2008 BYOTROL PLC Latest Developments Byotrol plc ("Byotrol" or the "Company"), the leading anti-microbial technologycompany is pleased to be able to provide an update on recent developments acrossthe business. Agricultural Sector - Contract The Company has secured a contract to supply The Active Group, a UK basedproducer and distributor of agricultural products, with a range of hoof and teatcare products containing Byotrol technology in both concentrate and pre-mix formfor use by livestock farmers. Products to the value of £250,000 are to bedelivered in March 2008 and the annual call off is expected to be around £1million in the first year. The Directors of Byotrol believe the dairy cattle sector will be an importantmarket for the Company and expenditure on sanitising products is estimated to beworth in excess of £35 million per annum in the UK, with equally significantopportunities in Western Europe and North America. The Company's teat and hoof care products were launched at one of the UK'sleading agricultural events, the Royal Bath and West of England Dairy Show, inJanuary this year. Food Sector - Marks and Spencer ("M&S") Accreditation and Heinz Order The Company is very pleased to report that M&S has approved Byosan as anApproved Terminal Disinfectant for use within M&S's Food Manufacturing SupplyChain. Accordingly, Byotrol is now approved to supply organisations that processand manufacture food products on behalf of M&S. Approval was granted following an eight month, three stage project involvinginitial laboratory verification of the technology by the Campden and ChorleywoodFood Research Association followed by a period of commercial validationconducted by Pennine Foods (part of Northern Foods). Hygiene, technical andfinal commercial validation was conducted in conjunction with Pennine Foods. In the Director's opinion the approval with M&S opens up potentially significantsales opportunities following the approval with one of the UK's most reputablefood retailers. It also opens up sales opportunities within Northern Foods, as aresult of the work conducted with Pennine Foods. The Company has also secured its first order to supply food manufacturer H JHeinz with Byotrol technology in one of its facilities in Cumbria. The initialorder follows extensive evaluation conducted by H J Heinz to establish theefficacy of the Byotrol technology. Studies of Byotrol products are beingconducted at other Heinz sites. Healthcare Sector - Care UK Deployment Complete and Pre-School Care Order The Company's health distribution partner, Synergy Healthcare, has completed theinstallation of more than 4,000 hand dispensers that use hand hygiene productscontaining Byotrol technology into Care UK, a leading independent provider ofhealth and social care service solutions. The completion of this installationwill lead to an annual ongoing provision of product to Care UK. The Company has also secured an initial order for £30,000 of product to besupplied for use in the pre-school and playgroup sectors where Byotroltechnology is being used under the Toyguard brand to enable playgroup operatorsto clean equipment and toys used in the pre-school setting. Consumer Products Byotrol's joint venture, Byotrol Consumer Products limited, set up with leadinginnovation company What If, continues to make strong progress with a number ofleading companies in the target consumer goods sectors and the business plan forthis joint venture is in line with the original timescales set out at the timeof launch. Commenting on these developments Stephen Falder, Deputy Chairman of Byotrol plcsaid:- "In the food sector we have set out to secure accreditation and orders atthe very highest level with three of the UK's leading food manufacturers. Thesepave the way for sales right across the food industry supply chain. "We are now starting to demonstrate commercial returns across a number ofsectors and are looking to build on these successes in the months ahead." 27 February 2008 Enquiries: Byotrol plc 0161 277 9518 Stephen FalderDeputy Chairman Richard Bell 07825 204110Finance Director Charles Stanley Securities 020 7149 6457(Nominated Adviser)Philip Davies McCann Erickson PR 01625 822540Jim Rothnie Rawlings Financial 01756 770376John Rawlings This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
30th Apr 20247:00 amRNSCancellation - Byotrol Plc
29th Apr 20242:15 pmRNSSecondary Trading on Asset Match
23rd Apr 20246:00 pmRNSByotrol
22nd Apr 20244:44 pmRNSCapital Reorganisation Delay
22nd Apr 20241:27 pmRNSResults of General Meeting
15th Apr 202411:48 amRNSHolding(s) in Company
8th Apr 20247:00 amRNSHolding(s) in Company
2nd Apr 20243:27 pmRNSDirector Dealing
28th Mar 20247:00 amRNSProposed Cancellation
22nd Dec 202311:44 amRNSHolding(s) in Company
7th Dec 20237:00 amRNSHalf-year Report
14th Nov 20237:00 amRNSLaunch of PROCESSUS® Instrument Decontamination
14th Nov 20237:00 amRNSTrading Update
9th Nov 20233:43 pmRNSHolding(s) in Company
27th Sep 20237:00 amRNSBoard Changes
13th Sep 20233:33 pmRNSResult of AGM
8th Sep 20234:33 pmRNSDirector Dealing
7th Sep 20237:01 amRNSBoard Appointment
7th Sep 20237:00 amRNSTrading Update
29th Aug 20238:51 amRNSLaunch of CHEMGENE MEDLAB into human healthcare
23rd Aug 20237:00 amRNSInvestor Presentation via Investor Meet Company
31st Jul 20237:00 amRNSFinal Results
6th Jul 20237:00 amRNSPatent Grant for Novel Anti-viral Seaweed Extract
24th May 20233:14 pmRNSUS EPA approves Byotrol24 as long-lasting virucide
24th May 20238:51 amRNSDirector Dealing
28th Apr 20239:57 amRNSDirector Dealing
27th Apr 20237:00 amRNSTrading Update and Board Changes
1st Feb 20239:52 amRNSDirector Dealing
22nd Dec 20223:08 pmRNSDirector Dealing
19th Dec 202210:00 amRNSDirector Dealing
16th Dec 20227:00 amRNSGrant of Share Incentive Awards
12th Dec 20227:00 amRNSInterim results and Investor Presentation
22nd Nov 20227:00 amRNSDirectorate Changes
27th Sep 202211:15 amRNSPDMR Shareholding
22nd Sep 20225:21 pmRNSResult of AGM
8th Sep 20227:00 amRNSDirector Dealing
2nd Sep 202210:02 amRNSInvestor Presentation
30th Aug 20227:00 amRNSFinal Results
12th Aug 20223:30 pmRNSDirector Dealing
28th Jul 20227:00 amRNSCompletion of Convertible Loan Note Fundraising
11th Jul 20227:00 amRNSTrading Update and Notice of Results
22nd Apr 20229:14 amRNSHolding(s) in Company
2nd Mar 20227:00 amRNSTrading Update
12th Jan 20227:00 amRNSSenior Management Appointment
14th Dec 20219:06 amRNSSecond Price Monitoring Extn
14th Dec 20219:00 amRNSPrice Monitoring Extension
13th Dec 20217:00 amRNSDirectorate Change
9th Dec 20218:51 amRNSDirector Dealing
8th Dec 20217:00 amRNSInterim Results and Investor Presentation
2nd Nov 20217:00 amRNSDirectorate and Senior Management Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.